Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort

Author： Ho Won Jin Simon Michael S. Yildiz Vedat O. Shikany James M. Kato Ikuko Beebe-Dimmer Jennifer L. Cetnar Jeremy P. Bock Cathryn H.

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|4|580-588

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.4, 2015-02, pp. : 580-588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma

By Mohamed Ateesha F.

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 977-988

Adis International

Access to resources Recommend Favorite

Lapatinib and renal cell carcinoma

By Gross-Goupil Marine Bernhard Jean-Christophe Ravaud Alain

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1727-1732

Informa Healthcare

Access to resources Recommend Favorite

Everolimus: In Advanced Renal Cell Carcinoma

By Garnock-Jones Karly P. Keating Gillian M.

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2115-2124

Adis International

Access to resources Recommend Favorite

Emerging drugs for renal cell carcinoma

By Varella Leticia Rini Brian I

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 343-353

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant treatment for renal cell carcinoma

By Lam John S Belldegrun Arie S Figlin Robert A

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 705-720

Informa Healthcare

Access to resources Recommend Favorite